MR imaging of edema accompanying benign and malignant bone tumors

To evaluate the incidence, quantity, and presentation of intra- and extraosseous edema accompanying benign and malignant primary bone lesions, the magnetic resonance (MR) studies of 63 consecutive patients with histologically proven primary bone tumors were reviewed. MR scans were assessed for the presence and quantity of marrow and soft tissue edema and correlated with peroperative findings, resected specimens and follow-up data. The signal intensity and enhancement of tumor and edema prior to and after intravenous administration (if any) of gadolinium-labled diethylene triamine pentaacetate (Gd-DTPA) was analyzed. Marrow edema was encountered adjacent to 8 of 39 malignant tumors and 14 of 24 benign lesions. Soft tissue edema was found accompanying 28 of 39 malignancies and 10 of 24 benign disorders. On unenhanced T1-weighted MR images tumor and edema were difficult to differentiate. Tumor inhomogeneity made this differentiation easier on T2-weighted sequences. In 36 patients the contrast medium Gd-DTPA was used. Edema was present in 27 of these patients and the respective enhancement of tumor and edema could be compared. Edema always enhanced homogeneously, and in most cases it enhanced to a similar degree as or more than tumor. Marrow and, more specifically, soft tissue edema is a frequent finding adjacent to primary bone tumors. The mere presence and quantity of marrow and soft tissue edema are unreliable indicators of the biologic potential of a lesion. Unenhanced MR scans cannot always differentiate between tumor and edema, but the administration of Gd-DTPA is of assistance in differentiating tumor from edema. Awareness of marrow and/or soft tissue edema adjacent to bone lesions is of importance because edema can be a pitfall in the diagnostic work-up and staging prior to biopsy or surgery.     

Nerve sheath tumors: evaluation with CT and MR imaging.

Tumors of nerves are classified into benign (schwannoma and neurofibroma) and malignant nerve sheath tumors. Schwannomas almost always occur as solitary lesions, whereas neurofibromas may occur alone or in a greater number, especially in patients with the peripheral form of von Recklinghausen's disease. Benign nerve sheath tumors often present as asymptomatic, slowly growing soft tissue masses. Although malignant nerve sheath tumors are relatively rare, a sudden increase in the size of a lesion, in particular in a patient with neurofibromatosis, should raise the suspicion of malignant change. On computed tomography (CT) and magnetic resonance imaging (MR) a benign nerve sheath tumor usually appears as a well-defined, oval, spherical or fusiform mass with smooth borders and distinct outlines, located in the subcutaneous tissue or centered at the expected anatomic location of a nerve, with displacement of adjacent soft tissues. Generally nerve sheath tumors have a low density on unenhanced CT scans. On MR they are isointense to muscle on T1-weighted images, whereas on T2-weighted images the signal intensity is high. Both on CT and MR the degree of contrast enhancement is moderate to marked and may be homogeneous or inhomogeneous. MR has become the method of choice for evaluating the anatomic location, contour, and relation of a nerve sheath tumor to adjacent neural, vascular, and muscular structures. The imaging criteria for malignant nerve sheath tumors are not specific enough to distinguish them from other malignant soft tissue tumors, so that neither CT nor MR can establish a definite diagnosis.     

Malignant parotid tumors: clinical use of MR imaging and histologic correlation.

Magnetic resonance (MR) imaging was performed in 116 patients in whom a parotid mass lesion was clinically suspected. Eighty-six patients had benign disease. The 30 patients in whom a malignant tumor was found were further evaluated. To determine which features are characteristic of malignant parotid tumors, spin-echo T1- and T2-weighted images of malignant lesions in the parotid gland were compared with those of benign disease. In our series, tumor margins, homogeneity, or signal intensity were not discriminative factors to correctly predict benign or malignant disease. Infiltration into deep structures (eg, the parapharyngeal space, muscles, and bone) was observed only in malignant tumors. Infiltration into subcutaneous fat was noticed in malignant as well as in inflammatory disease. No statistically significant correlation was found between tumor grade and MR imaging features in malignant disease. MR imaging is useful in delineating malignant tumors but is unreliable in correctly predicting the histologic nature of a mass lesion in the parotid gland.     

Usefulness of diffusion-weighted MRI in differentiating benign from malignant musculoskeletal tumors

PURPOSE: To evaluate the usefulness of diffusion-weighted MRI in distinguishing different components and in differentiating benign from malignant musculoskeletal tumors. MATERIALS AND METHODS: Fifty-seven patients with musculoskeletal tumors underwent MR at our institution from October 1999 to April 2002. We evaluated 57 tumors (9 bone tumors and 48 soft tissue tumors). All tumors were classified into 8 groups (myxomatous, fibrous, cystic, cartilaginous, fatty components, hematomas, other benign tumors, and other malignant tumors). MR examinations were performed with a 1.5-Tesla system. Diffusion-weighted single-shot EPI images were obtained in all patients. Apparent diffusion coefficients (ADCs) were calculated by using b factors of 0 and 1,000 sec/mm2. RESULTS: ADC values of myxomatous, cystic, and cartilaginous components were significantly higher than those of other tumors. In cartilaginous tumors, malignant tumor ADC values (2.33 +/- 0.44) were higher than those of benign tumors (2.13 +/- 0.13). However, there was no significant difference between benign and malignant tumors. Except for high-intensity components on T1-weighted imaging and low or homogeneously very high intensity components on T2-weighted imaging, there was a significant difference in ADC between malignant (1.35 +/- 0.40) and benign (1.97 +/- 0.50) tumors. CONCLUSION: Within the limited number of cases, there was a significant difference in ADC between malignant and benign tumors.     

Central scars in primary liver tumors: MR features, specificity, and pathologic correlation

Tumor scars were identified at pathologic study and magnetic resonance (MR) imaging in ten of 17 (59%) primary liver tumors (nine hepatocellular carcinomas, four giant hemangiomas, two hepatic adenomas, and two cases of focal nodular hyperplasia). Histopathologic examination revealed three types of scar tissue. Inflammatory scars (n = 4), with edema, necrosis, hypercellularity, and loose fibrous tissue, appeared hypointense relative to liver on T1-weighted images and hyperintense on T2-weighted images. Vascular scars (n = 3), predominantly composed of vascular channels traversing collagenous tissue, showed MR features similar to those of inflammatory scars. Collagenous scars (n = 3) appeared hypointense relative to liver on both T1-weighted and T2-weighted images. Central tumor scars are a frequent but nonspecific feature of both benign and malignant primary liver tumors.     

Cross-sectional imaging of primary osseous hemangiopericytoma

The aim of this study was to assess cross-sectional imaging features and the value of CT and MRI in primary hemangiopericytoma of bone. In five patients with histologically proven primary osseous hemangiopericytoma CT and MR scans were evaluated retrospectively. Both CT and MRI were available in four patients each. In three patients both imaging techniques were available. On CT primary hemangiopericytoma of bone presents as an expansive lytic lesion with bone destruction and inhomogeneous contrast enhancement. Magnetic resonance imaging depicts osseous hemangiopericytoma as hyperintense lesion on T2-weighted images with intermediate signal intensity on T1-weighted images. Curvilinear tubular structures of signal void in the tumor matrix on T1-weighted images and corresponding hyperintense structures on T2-weighted and on fat-suppressed short tau inversion recovery images were present in three patients. Although cross-sectional imaging findings are non-specific, they add to the diagnosis and provide valuable information about the extent of bone destruction and local tumor spread in patients with primary osseous hemangiopericytoma. While CT demonstrates the extent of bone destruction best, MRI better visualizes medullary and soft tissue extension of the tumor. Curvilinear signal abnormalities support the diagnosis of hemangiopericytoma of bone. This imaging pattern is best visualized on fat-suppressed or contrast enhanced T1-weighted MR images.     

MR imaging of benign and malignant lesions in the buccal space

OBJECTIVES: To evaluate MRI characteristics of buccal space lesions and to discuss the sensitivity of MRI in predicting malignancy of those lesions. METHODS: Thirty patients with malignant (n=7) or benign (n=23) lesions originating in the buccal space were reviewed retrospectively. MR images were assessed for the margins, internal architecture, signal intensity of lesions and their relation to the surrounding structures. RESULTS: Two cases of soft tissue sarcoma were shown as ill-defined masses with infiltration into adjacent muscles and bone. On the other hand, all tumors of minor salivary gland origin, whether malignant (n=4) or benign (n=2), were well-defined and confined within the buccal fat pad without infiltration into surrounding structures. All haemangiomas (n=9) had very high T2-weighted signal intensity. Three out of them contained signal voids on all sequences thought to represent phleboliths, a finding strongly suggestive of the diagnosis. Inflammatory lesions were characterized by the presence of edema in the surrounding fat. When ill-defined margins, infiltration into muscles and bone destruction were used as the criteria for the malignancy, only two out of seven malignant tumors were correctly diagnosed (sensitivity 29%). CONCLUSIONS: Although MR imaging was useful in demonstrating the extent of buccal space lesions, its diagnostic value in predicting malignancy was very limited. It was especially true for malignant tumors of minor salivary gland origin, which were typically seen as well-defined masses without infiltration into surrounding structures on MRI.     

Eosinophilic granuloma: MRI manifestations

The appearance on magnetic resonance imaging (MRI) of 16 cases of pathologically proven eosinophilic granuloma were reviewed retrospectively and correlated with the radiographic appearance of the lesion. The most common MR appearance (ten cases) was a focal lesion, surrounded by an extensive, ill-defined bone marrow and soft tissue reaction with low signal intensity on T1-weighted images and high signal intensity on T2-weighted images, considered to represent bone marrow and soft tissue edema (the flare phenomenon). The MRI manifestations of eosinophilic granuloma, especially during the early stages, are nonspecific, and may simulate an aggressive lesion such as osteomyelitis or Ewings sarcoma, or other benign bone tumors such as osteoid osteoma or chrondroblastoma.     

MR imaging of extraabdominal desmoids: differentiation from other neoplasms.

A retrospective review of MR images of 36 patients with histologically proved extraabdominal desmoids was done to define the MR characteristics of these tumors and to determine if MR could be used to differentiate desmoids from other benign and malignant soft-tissue neoplasms. The desmoids evaluated included eight primary and 30 recurrent lesions. Our study was conducted in parallel with another study in which the MR appearance of 95 benign and malignant soft-tissue masses was evaluated, and the MR images of these masses were compared with our findings. The four desmoids from that study are included in our data. The signal intensity of the tumor on T1- and T2-weighted images was graded relative to the intensities of muscle and fat. Homogeneity, margin, neurovascular and bone involvement, and fibrosis (low-signal regions within the tumor on both T1- and T2-weighted images) were evaluated. On MR imaging, the desmoids showed inhomogeneous signal (97%), poor margination (89%), neurovascular involvement (58%), and bone involvement (37%). Fibrosis was present in 88% of primary desmoids and 90% of recurrent ones, and intermediate signal (greater than that of muscle and less than that of fat) was present in 75% and 50% of these, respectively. Our results show that the MR features of desmoids have characteristics that are commonly found in malignant tumors (inhomogeneous signal, poor margination, and neurovascular involvement). MR features of desmoids that distinguish them from malignant neoplasms are the presence of fibrosis and intermediate signal in the regions of the tumor.     

Fibrous histiocytoma and fibrous tissue tumors of the orbit

Fibrous orbital tumors present clinically and radiographically in a broad spectrum ranging from a benign mass, to locally aggressive tumor, to invasive malignancy. Pathologic analysis and diagnosis are often challenging, usually based on a combination of light microscopy, immunohistochemistry, and electron microscopic findings. Some light microscopic and immunohistochemical findings, however, are relatively characteristic. A storiform or cartwheel pattern and vimentin staining are characteristic of fibrous histiocytoma. A herringbone pattern is usually found in fibrosarcoma. A "patternless pattern" and CD34 staining is found most commonly in solitary fibrous tumor. CT and MR imaging findings, as well as clinical presentation, in fibrous orbital lesions are often difficult to distinguish from those of other orbital masses, although there may be useful clues. Benign fibrous lesions are usually well-circumscribed and may chronically remodel bone, whereas more aggressive malignant fibrous tumors tend to have infiltrating margins and may destroy bone on CT or MR imaging. With malignant fibrous masses, enhancement patterns on CT or MR imaging may be more inhomogeneous, with avascular or necrotic nonenhancing regions. At MR imaging, benign lesions tend to be homogeneous on T1, T2, and postgadolinium T1-weighted images, whereas malignant soft tissue lesions may change their pattern from homogeneous on T1-weighted images to heterogeneous with low signal septations on T2-weighted images. Low T2 signal comprising part or all of a fibrous lesion correlates with dense collagen fibers, with a less cellular matrix. Areas of hyperintensity on T2-weighted images correspond with a more cellular matrix of fibroblasts and other cells. Calcification within a tumor, however, may give a similar appearance. Thus, if a lesion has predominantly low signal on T2-weighted images, or less specifically has low signal septations, then a fibrous orbital lesion with high collagen content may be ranked higher in the differential diagnosis (see Figs. 2E and 3B). When T2 signal is intermediate-to-high, then one has a difficult time narrowing the differential diagnosis. Radiographically, distinguishing these lesions from other fibrous orbital lesions, as well as from other varieties of orbital masses, is difficult. Differential diagnosis of fibrous orbital masses includes all the fibrous lesions described in this article, in addition to schwannoma (Fig. 7), neurofibroma (Figs. 4 and 8), hemangiopericytoma (Figs. 9 and 10), rhabdomyosarcoma, meningioma, lymphoma, and metastasis (Figs. 11 and 12). A history of prior orbital irradiation for retinoblastoma or other tumors may raise the possibility of radiation-induced secondary tumors, such as MFH, fibrosarcoma, and osteosarcoma. Determining the extent of orbital involvement remains the primary goal of the radiologist. The final diagnosis still rests with the pathologist.     

CT-MR image data fusion for computer assisted navigated neurosurgery of temporal bone tumors

PURPOSE: To demonstrate the value of multi detector computed tomography (MDCT) and magnetic resonance imaging (MRI) in the preoperative work up of temporal bone tumors and to present, especially, CT and MR image fusion for surgical planning and performance in computer assisted navigated neurosurgery of temporal bone tumors. MATERIALS AND METHODS: Fifteen patients with temporal bone tumors underwent MDCT and MRI. MDCT was performed in high-resolution bone window level setting in axial plane. The reconstructed MDCT slice thickness was 0.8 mm. MRI was performed in axial and coronal plane with T2-weighted fast spin-echo (FSE) sequences, un-enhanced and contrast-enhanced T1-weighted spin-echo (SE) sequences, and coronal T1-weighted SE sequences with fat suppression and with 3D T1-weighted gradient-echo (GE) contrast-enhanced sequences in axial plane. The 3D T1-weighted GE sequence had a slice thickness of 1mm. Image data sets of CT and 3D T1-weighted GE sequences were merged utilizing a workstation to create CT-MR fusion images. MDCT and MR images were separately used to depict and characterize lesions. The fusion images were utilized for interventional planning and intraoperative image guidance. The intraoperative accuracy of the navigation unit was measured, defined as the deviation between the same landmark in the navigation image and the patient. RESULTS: Tumorous lesions of bone and soft tissue were well delineated and characterized by CT and MR images. The images played a crucial role in the differentiation of benign and malignant pathologies, which consisted of 13 benign and 2 malignant tumors. The CT-MR fusion images supported the surgeon in preoperative planning and improved surgical performance. The mean intraoperative accuracy of the navigation system was 1.25 mm. CONCLUSION: CT and MRI are essential in the preoperative work up of temporal bone tumors. CT-MR image data fusion presents an accurate tool for planning the correct surgical procedure and is a benefit for the operational results in computer assisted navigated neurosurgery of temporal bone tumors.     

Bone tumors: magnetic resonance imaging versus computed tomography

The magnetic resonance (MR) imaging characteristics of bone tumors are described and the clinical utility of MR imaging in patient evaluation is reported. Fifty-two patients with skeletal lesions were examined with a Picker MR imager (0.15-T resistive magnet). Twenty-five patients had primary malignancies, seven had benign bone neoplasms, 15 had skeletal metastases, and five had neoplasm simulators. Forty-five patients had CT scans available for comparison. For demonstrating the extent of tumor in marrow, MR was superior to CT in 33% of cases, about equal to CT in 64%, and inferior to CT in 2%. For delineating the extent of tumor in soft tissue, MR was superior to CT in 38% of cases and about equal to CT in 62%. CT was superior in all cases for demonstrating calcific deposits and pathologic fractures. In four patients with metal prostheses or surgical clips, MR was superior to CT in documenting recurrent tumor because of artifactual degradation of the CT image. Direct sagittal and coronal images from MR permit accurate assessment of the relationship of tumor to adjacent normal structures, including the physis, joints, and neurovascular structures. MR is useful in the evaluation of bone tumors: it is of greatest value in evaluations of the peripheral skeleton, the medullary canal, soft tissues, and postoperative tumor recurrence. With a 0.15-T magnet, MR is less useful in the evaluation of the axial skeleton and cortical bone.     

Use of MR imaging to assess results of chemotherapy for Ewing sarcoma

MR imaging was used to monitor the results of initial chemotherapy of primary Ewing sarcoma of bone. The signal intensities of the soft-tissue and marrow components of the tumor were evaluated on T2-weighted images obtained in 10 patients (nine with responsive tumors) at presentation and during and immediately after completion of two cycles of chemotherapy. MR evidence of marrow and soft-tissue involvement was seen in all tumors at presentation. After treatment, the bone-marrow component of the nine drug-sensitive tumors showed an increase in signal intensity that in eight cases became comparable to that of water. Changes in signal intensity of the soft-tissue component were variable, consisting of increases in two of the responsive lesions, no change in three, a decrease in two, and complete resolution of the soft-tissue mass in two. There was no increase in signal intensity of either the bone-marrow or the soft-tissue component of the single nonresponsive tumor. All of the responsive tumors showed advanced healing, and abundant bony sclerosis was apparent on CT. Bone-marrow examinations, performed in seven of the nine patients with responsive lesions, disclosed no evidence of tumor in four. Two patients had residual extramedullary tumor; the nonresponsive lesion contained sheets of tumor cells. The increase in marrow signal intensity on T2-weighted images was associated with replacement of marrow elements by a loose, hypocellular myxoid matrix containing modest amounts of collagen, consistent with response to chemotherapy and eradication of disease. Therefore, an increase in the T2-weighted signal intensity of the bone-marrow component of Ewing sarcoma of bone reflected a favorable response to chemotherapy. MR signal changes, however, were not predictive of resolution of malignant disease within adjacent soft tissue.     

Improved detection and delineation of head and neck lesions with fat suppression spin-echo MR imaging.

To compare conventional and fat suppression MR imaging in their ability to detect head and neck lesions, we prospectively studied 17 patients with head and neck tumors and one normal volunteer. Five patients had benign tumors (one mixed cell tumor, one hemangioma, one lipoma, and two plexiform neurofibromas), 10 had malignant tumors (six squamous cell carcinomas, two minor salivary gland carcinomas, one lymphoma, and one malignant fibrous histiocytoma), and two had nonspecific lymphadenopathy. All subjects were studied with standard spin-echo T1- and T2-weighted images (T2-weighted imaging was done with and without fat suppression technique). In addition, T1-weighted images with contrast enhancement and fat suppression were obtained in nine patients. A four-point grading system was used for comparison of the conventional and fat suppression images. Grades ranged from 0 (unsatisfactory, the lesion cannot be seen) to 3 (excellent, the lesion and its margins can be seen clearly with sharp contrast from surrounding normal tissue). We found that postcontrast fat suppression T1-weighted images and fat suppression T2-weighted images were most useful; these sequences obtained an average score close to grade 3 (2.77 and 2.85, respectively). On the other hand, the conventional T2-weighted images had an average score of about 2 (1.82) and the conventional T1-weighted image had a score of about 1 (1.33). Fat suppression T2-weighted sequences generally were superior in cases of lymphadenopathies. Postcontrast T1-weighted images were most useful in a case of plexiform neurofibroma, owing to their fibrous component and lower proton density.(ABSTRACT TRUNCATED AT 250 WORDS)     

Muscle edema in musculoskeletal tumors: MR imaging characteristics and clinical significance.

To determine the frequency and clinical significance of tumor-associated muscle edema, magnetic resonance (MR) imaging findings in 46 consecutive patients with benign or malignant musculoskeletal lesions were reviewed. Increased muscle signal intensity on T2-weighted, STIR (short-inversion-time inversion-recovery), and gadopentetate dimeglumine-enhanced T1-weighted images was present in 41 cases, with the clearest delineation of tumor margins seen on T2-weighted images. Typical peri/paratumoral edema (PTE) was present in equal proportions of malignant (25 of 37) and benign lesions (six of nine). Massive edema involving the entirety of at least one contiguous muscle--to the authors' knowledge, a previously undescribed finding--was identified on MR images of eight malignant and two benign lesions (22% of both groups). All cases of massive edema had a substantial soft-tissue component and involved muscles disrupted by tumor at the point of attachment to bone. Malignant tumors associated with massive edema were larger than those with typical or no PTE, showed a poorer response to initial chemotherapy, and had a higher frequency of metastases at diagnosis. Thus, the presence of massive muscle edema appears to be an ominous clinical finding in patients with malignant musculoskeletal lesions.     

CT and MR of neurofibromatosis of the bladder.

Neurofibromatosis of the genitourinary system is rare. We present the CT and MR findings of neurofibromas of the bladder in three patients with von Recklinghausen disease (neurofibromatosis, Type 1). In one case, genitourinary involvement was the primary presentation of the disease. Both CT and MR imaging revealed diffuse and nodular bladder wall involvement, along with pelvic sidewall and adjacent soft tissue abnormalities. The CT attenuation coefficients measured near soft tissue density. On T1-weighted spin echo MR images the tumors revealed signal intensity slightly greater than that of skeletal muscle. Neurofibromas showed markedly increased signal intensity on T2-weighted images relative to the surrounding soft tissues, with marked enhancement in two cases imaged following Gd-DTPA administration. Obstructive hydronephrosis was present in all cases, presumably due to neurofibromas involving the trigonal region. Pelvic sidewall tumors were visualized as rounded, nodular masses extending into the obturator foramina. In the evaluation of patients with von Recklinghausen disease, MR imaging, compared with CT, more clearly defined tumor extent within the bladder, pelvic sidewalls, and surrounding soft tissues.     

软组织炎性成肌纤维细胞瘤的MRI表现

目的 探讨软组织炎性成肌纤维细胞瘤(IMT)的MRI表现特点.方法 回顾性分析经手术病理证实的11例软组织IMT的MRI、手术及肿瘤组织病理资料.结果 肿瘤的病理分型为Ⅰ型1例,Ⅱ型4例,以Ⅱ型为主混杂有Ⅰ型3例,以Ⅱ型为主混杂有Ⅲ型3例.4例原发肿瘤呈类圆形,边界清楚,有假包膜;2例胭窝原发肿瘤及5例复发肿瘤形态不规则,边界欠清,侵犯周围组织.肿瘤于T1WI主要表现为等信号.不同病理分型的肿瘤于T2WI信号强度不同:1例Ⅰ型肿瘤呈高信号;4例Ⅱ型肿瘤和以Ⅱ型为主混杂有Ⅰ型的3例肿瘤均表现为稍高信号;以Ⅱ型为主混杂有Ⅲ型的3例肿瘤表现为等或稍低信号.11例肿瘤于T2WI在高信号、稍高信号或等信号背景下均见散在的斑点、小片状相对低信号灶(称之为"火龙果切面征").增强扫描11例肿瘤均见明显不均匀强化.6例原发IMT中,4例术后复发,1例无复发,1例失访.5例复发IMT中,2例术后再次复发,3例失访.结论 软组织IMT的MRI表现有一定的特征性.T2WI瘤体的信号强度反映软组织IMT的病理学分型."火龙果切面征"可能为能够反映软组织IMT病理特征的MR征象.     

MRI of bone tumors: Fast STIR imaging as a substitute for T1-weighted contrast-enhanced fat-suppressed spin-echo imaging

PURPOSE: To compare the usefulness of short inversion recovery (STIR) and T1-weighted, contrast-enhanced, fat-suppressed (T1W-CEFS) sequences for the evaluation of bone tumors. MATERIALS AND METHODS: Eighteen patients with 19 bone tumors who underwent both STIR and T1W-CEFS imaging were evaluated. The tumors were categorized in pairs as follows: bone marrow and soft-tissue components, benign and malignant tumors, and tumors with and without mineralization. The signal difference-to-noise ratio (SDNR), signal-to-noise ratio (SNR), and tumor volume were calculated in each group. An additional qualitative analysis was performed by means of the ratings of imaging contrast. RESULTS: The mean SDNRs of all bone marrow components and bone marrow components without mineralization were significantly higher on fast STIR images than on T1W-CEFS images (P < 0.05). There was no significant difference in the mean SDNR and SNR of the other group (surrounding soft tissue components, bone marrow components with mineralization, benign and malignant lesions) between fast STIR images and T1W-CEFS images. The mean volume of the tumors was significantly higher with STIR than with the T1W-CEFS sequence (P < 0.05). CONCLUSION: The STIR sequence should be used instead of T1W-CEFS imaging for the evaluation of bone tumors.     

Imaging of tumors of the spine and spinal cord

Imaging of the spine and spinal cord has traditionally been accomplished with plain radiography, myelography, and CT. Recently, MR imaging has become the technique of choice in the assessment of lesions of the spine and spinal cord. MR imaging provides accurate localization of intramedullary, intradural extramedullary, and extradural tumors. Ependymomas and low-grade astrocytomas are the most common intramedullary tumors. MR imaging findings are distinguishable by the delineation and size of the lesion, and the signal intensity on T2-weighted images. Other less common tumors include malignant astrocytomas, hemangioblastomas, and intramedullary metastasis. Numerous foci of high-velocity signal loss are seen in the hemangioblastomas. Metastasis, meningiomas, and schwannomas are the most common intradural extramedullary tumors. Meningiomas are characterized by dural enhancement on postcontrast T1-weighted images. Schwannomas and neurofibromas often erode bony structures and appear to be dumbbell-shaped. Epidural metastasis accounts for the majority of extradural tumors. Primary malignant extradural tumors include lymphomas, chordomas, and so on. The most common primary benign extradural tumor is hemangioma, which often appears to be hyperintense on both T1-weighted and T2-weighted images. Intramedullary non-neoplastic lesions include demyelinating, vascular, and infectious diseases. Diffuse, peripheral, or speckled contrast enhancement, and lack of contrast enhancement may suggest non-neoplastic lesions.     

Small hepatocellular carcinoma treated with percutaneous ethanol injection: MR imaging findings.

Fifty-seven magnetic resonance (MR) imaging examinations were obtained at 0.5 T in 19 patients before and after percutaneous ethanol injection (PEI) for 23 hepatocellular carcinoma (HCC) lesions less than 3.5 cm in diameter. Seventeen patients also underwent MR imaging 6 months after completion of therapy. In 11 patients, computed tomography was performed before and after treatment. After PEI, fine-needle biopsy specimens were obtained in all cases. Before treatment, HCC lesions had low signal intensity on T1-weighted images in 13 cases, had the same signal intensity as normal liver parenchyma in six, and had high signal intensity in four; all 23 tumors had high signal intensity on T2-weighted images. After treatment and at 6-month follow-up, all 21 lesions that contained no malignant cells at fine-needle biopsy had high signal intensity on T1-weighted images and had low signal intensity on T2-weighted images. The remaining two HCC lesions in which tumor necrosis was not achieved with PEI displayed a different MR pattern, since the residual neoplastic tissue showed no change in signal intensity on either T1- or T2-weighted images. The authors conclude that MR imaging may be useful for evaluating the effectiveness of PEI in achieving tumor regression.